Why we started
Global food systems are under pressure from volatility, waste, and rising resource costs. We saw a practical opportunity: convert lower-value by-products into high-value protein through insect agriculture.
The challenge
Conventional protein supply chains are increasingly exposed on cost, resilience, and footprint.
Our answer
UK-grown cricket protein with traceability, quality control, and credible routes from pilot to scale.
What we've built so far
A complete, functional ingredient — with a fraction of the environmental footprint of conventional protein sources.
Operational farm capability
Live UK cricket production with active scaling work across throughput and process reliability.
National R&D network
Active collaborations with universities and researchers across nutrition, health, and circular agriculture.
Commercial readiness
Buyer-focused delivery: dependable supply pathways, technical documentation, and practical onboarding.
“The goal was never to look innovative on paper — it was to build a real UK protein business that can deliver”, edibl's founders
Our collaborators
Within the Cranfield University investment portfolio, R&D funding from Innovate UK, and innovation activity across the UK.
Why now
Insect protein has moved beyond theory. Brands, product teams, and partners now want implementation — fast, credible, and commercially grounded.
Market pull
More demand for resilient, differentiated protein ingredients.
Circular pressure
Supply chains are being redesigned around waste-to-value opportunities.
Execution gap
Few operators can bridge science, regulation, and delivery — that’s where edibl sits.
Next Phase
What's next for edibl
We’re focused on scaling output, deepening strategic partnerships, and widening routes for ingredient and white-label growth.
Scale
Expand production consistency and volume bands.
Partner
Build stronger retailer, research, and supply-chain partnerships.
Broaden
Open more product pathways across ingredient and finished formats.
Deliver
Shorten timelines from first enquiry to commercial output.